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Abstract
Mucopolysaccharidosis type I (MPS I) arises from a deficiency in the -L-iduronidase (IDUA) enzyme. Although the
clinical spectrum in MPS I patients is continuous, it was possible to recognize 3 phenotypes reflecting the severity of
symptoms, viz., the Hurler, Scheie and Hurler/Scheie syndromes. In this study, 10 unrelated Chinese MPS I families
(nine Hurler and one Hurler/Scheie) were investigated, and 16 mutant alleles were identified. Three novel mutations
in IDUA genes, one missense p.R363H (c.1088G > A) and two splice-site mutations (c.1190-1G > A and c.792+1G >
T), were found. Notably, 45% (nine out of 20) and 30% (six out of 20) of the mutant alleles in the 10 families studied
were c.1190-1G > A and c.792+1G > T, respectively. The novel missense mutation p.R363H was transiently ex-
pressed in CHO cells, and showed retention of 2.3% IDUA activity. Neither p.W402X nor p.Q70X associated with the
Hurler phenotype, or even p.R89Q associated with the Scheie phenotype, was found in this group. Finally, it was
noted that the Chinese MPS I patients proved to be characterized with a unique set of IDUA gene mutations, not only
entirely different from those encountered among Europeans and Americans, but also apparently not even the same
as those found in other Asian countries.
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Mucopolysaccharidosis type I (MPS I, McKusick
252800) is an autosomal recessive disease, caused by a de-
ficiency in the lysosomal enzyme -L-iduronidase (IDUA,
E.C. 3.2.1.76). This leads to the accumulation of partially
degraded mucopolysaccharides, thereby giving rise to cer-
tain clinical conditions, expressed notably by the Hurler
(IH), Scheie (IS) and Hurler/Scheie (IH/S) syndromes
(Hopwood and Morris, 1990). The incidence rate of MPS-
IH is 1/100,000 to 1/150,000, thus making it, not only the
most common among all the forms of MPS, but also the
main one in Chinese MPS I patients, as a whole. IH is the
most severe, with symptoms developing during the first
year of life, as severe mental retardation, skeletal deformi-
ties, hepatosplenomegaly and corneal clouding. IS, on the
otherhand,besidesdevelopingatalaterperiodinlife,man-
ifests as aortic valve disease, stiff joints, corneal clouding
and mild visceral organic problems, albeit no mental retar-
dation. IH/S patients present most of the skeletal problems
associated with IH, but with symptoms developing during
the early to mid teens, associated with relatively little men-
tal retardation (Schuchman and Desnick, 1988). It has been
proposed that the variable severity of symptoms is an out-
come of the different types of pathogenic mutations in the
gene itself. Consequently, molecular biological analysis of
MPS I exerts an important role in diagnosis. To date, more
than 100 pathogenic mutations have been found in the
IDUA gene (Human Gene Mutation Database, 2010-03-
01), and the higher prevalence of several mutations in cer-
tain geographic locations, such as p.W402X and p.Q70X
among Caucasian patients (Bunge et al., 1994), has been
demonstrated.Identificationofthespecificmutationsinaf-
fected patients is useful both for prenatal diagnosis, as well
as genotype-phenotype correlations, although the mutant
type in Chinese mainland MPS-I patients is still unclear.
Herein are described the results of mutation analysis of
pathogenic mutations of the IDUA gene in a group of 10
Han Chinese MPS-I families, with a view to identifying the
major mutations specific to China.
The group of 10 MPS I families under study included
nine Hurler and one Hurler /Scheie patients. Primary clini-
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Short Communicationcal diagnosis was confirmed biochemically by the demon-
stration of increased excretion of urinary dermatan sulfate
andheparansulfateintheformer,andIDUAactivityiniso-
lated leukocytes in the latter. Blood samples were col-
lected, not only from the 10 patients, but also their respec-
tive parents. This study was approved by the Ethics
Committee of the first Hospital of China Medical Univer-
sity, with full informed consent by the parents. The -L-
iduronidase enzyme activities in leucocytes of the patients
were measured using the artificial substrate 4-methyl-
umbelliferyl -L-iduronide (Sigma). The data of enrolled
patients are summarized in Table 1.
Genomic DNA was extracted from venous blood by
using a modified version of the ammonium acetate salt-
ing-out method. The IDUA gene was amplified from ge-
nomic DNA covering the entire IDUA coding region and
exon – intron boundaries. Primer sequences, amplicon
length and PCR reaction temperature are listed in Table 2.
PCR was carried out in a mixture containing 200 ng of
DNA extracted from whole blood, 100 nM of each outside
primer, 10 mM of Tris – HCl, pH 8.3, 1.5 mM of KCl,
2 mM of MgCl2, 100 M of each deoxyribonucleotide, and
1unitofLATaqDNApolymerase(Takara),inatotalreac-
tion volume of 50 L. PCR conditions were as follows: de-
naturation at 95 °C, 3 min, followed by 35 cycles at 95 °C,
1min,62-68°C,1min,72°C,1min,andafinalelongation
at 72 °C, 7 min. Each resulting PCR product was run on an
8% PAGE gel with a 100-bp marker for comparison. Re-
striction enzyme tests were designed to screen for
p.W402X, p.Q70X (Clarke et al., 1994) and p.R89Q
(Yamagishi et al., 1996) (Table 3). Negative, heterozygous
and homozygous control samples were analyzed together
with patient samples. All 14 exons of the IDUA gene were
amplified and analyzed by means of single strand con-
formational polymorphism (SSCP) analysis. Electrophore-
sis was carried out overnight at 4 °C. Those samples
showing alterations were then sequenced. Mutations were
confirmed by direct sequencing the reverse strand and re-
striction analysis.
Thep.R363Hmutationwasintroducedintowild-type
IDUA cDNA which had been cloned into the pSP72 plas-
mid vector (Promega), by using the QuickChange site-
directed mutagenesis kit (Stratagene), according to manu-
facturer's instructions. Clones containing the mutagenized
IDUA cDNA constructs were sequenced to ensure that no
changes other than the desired mutation had been intro-
duced. Chinese Hamster Ovary (CHO) cells were trans-
fected with either the wild-type or a mutant cDNA
constructusinglipofectamine(Invitrogen).Foreachexper-
iment,2x1 0
5 cells were seeded 24 h prior to transfection.
Each construct was transfected in triplicate using 0.4 g
DNA and 5 L lipofectamine. Transfection complexes
were removed after 6 h and replaced with full-growth me-
dium. 24 h after transfection, efficiency was estimated by
the number of cells expressing EGFP, as observed through
an inverted fluorescent microscope. The cells were then
washed twice with phosphate-buffered saline (PBS) and
harvested in 1 mL of PBS, whereupon they were sonicated
in 50 L of sterile water, centrifuged at 2000 rpm for
10 min, and then stored on ice. IDUA enzyme activity was
measured with the artificial substrate 4-methylumbelliferyl
alpha-L-iduronide.Afterincubationfor1hat37°C,there-
actionwasterminatedbywayof1.14mLof0.25Mglycine
NaOH buffer, pH 10.4. The fluorescence of released
4-methylumbelliferone was measured with an excitation
wavelength of 365 nm and an emission wavelength of
450 nm (Young, 1992).
The common mutations, p.W402X and p.Q70X, as-
sociated with the Hurler phenotype, and p.R89Q, with the
Scheie phenotype, were not found by restriction digestion
of PCR products amplified from exon 2 and 9 of the IDUA
gene, in any of the ten families.
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Table 1 - Characteristics of the 10 Han Chinese MPS I patients.
Patient number/sex Phenotype Leukocyte IDUA activity
(nmol/h/mg protein)
Mutation identified Major clinical manifestations
1/m H 0 c.1190-1G > A/? Severe mental retardation, corneal clouding,
skeletal deformities, and hepatosplenomegaly
2/m H 0 c.1190-1G > A/c.1190-1G > A Same as above
3/m H 0 c.1190-1G > A/ c.792+1G > T Same as above
4/m H 0 c.792+1G > T/ c.792+1G > T Same as above
5/m H 0 c.1190-1G > A/c.1190-1G > A Same as above
6/m H 0 c.792+1G > T/? Same as above
7/m H 0 c.1190-1G > A/? Same as above
8/m H 0 c.792+1G > T/? Same as above
9/m H 0 c.1190-1G > A/ c.792+1G > T Same as above
10/F H/S 0.18 c.1190-1G > A/ p.R363H Hepatosplenomegaly, joint stiffness, corneal
clouding, and slightly mental delayAs shown in Table 1, the novel mutations found in-
cluded one p.R363H missense mutation (c.1088G > A) and
two splice-site mutations (c.1190-1G > A and c.792+1G >
T). None of these were detected in 50 normal persons after
direct sequencing of the PCR-amplified fragment contain-
ing intron 6, exon 8 and intron 8 of the IDUA gene, respec-
tively, thereby implying their not being polymorphisms,
but in fact new mutations. The splice-site mutations
c.1190-1G > A and c.792+1G > T were further analyzed at
the transcript level. The deletion of five exonic nucleotides
caused by c. 1190-1G > A, resulted in the shift of the splice
acceptor site of intron 8 (r.1189_1195del1190_1194), pre-
sumably leading to a frameshift, which started at the 397
th
amino acid residue and ended at a premature stop codon,
110 amino acid residues downstream (p.D397GfsX110).
The insertion of 17 intronic nucleotides caused by
c.792+1G > T, resulted in a shift of the intron 6 splice-
donorsite(r.792_793ins792+1_792+17),presumablylead-
ing to a frameshift, which started at the 265
th amino acid
residueandendedataprematurestopcodon,58aminoacid
residuesdownstream(p.G265LfsX58).Notably,45%(nine
out of 20) and 30% (six out of 20) of the mutant alleles in
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Table 2 - PCR primer sequences, amplicon length and PCR reaction temperature.
Exon Primer sequence Amplicon length (bp) Annealing temperature (°C)
1 F: 5'-ACCCAACCCCTCCCAC-3';
R: 5'-GCTCCGGTCTCTGAAGCT-3'
398 64
2 F: 5'-GGCTTGAACGTGTGTGTCAGCCGC-3';
R: 5'-GTAAGGGGCTCTGGGACGCCCAGA-3'
258 65
3 F: 5'-AGGTCCTGCCTGGCTCCTGA-3';
R: 5'-GGCTGGGAGCAGAGCCCACA-3'
450 66
4 F: 5'-ACCCTCTCCCTCACCCAG-3';
R: 5'-GCGTGATAGGGGTGCAAC-3'
312 64
5 F: 5'-CATCACCTTGCACCCTCC-3';
R: 5'-CGTCTACACCTGCCCTGG-3'
273 64
6 F: 5'-CCGCTCATCCCCAGGGCAGGTGTA-3';
R: 5'-ACAGCGGCTGAGGGCGCAGAACAC-3'
301 66
7 F: 5'-CGCGCTGACCCTGGTGGTGGTGA-3';
R: 5'-GCCGGGGGGCGCGCAGGGCGTT-3'
254 68
8 F: 5'-TTCCTCCCGAGACGGGACAGGCGA-3';
R: 5'-TTCCTCCCGAGACGGGACAGGCGA-3'
350 67
9 F: 5'- TGGGGACTCCTTCACCAAGGGGAG-3';
R: 5'-CAGAGCCCCAGCGGGGCCAGAGAC-3'
371 68
10 F: 5'-GGTGACCCTGCGGCTG-3';
R: 5'-TCCTCAGGGTTCTCCAGG-3'
421 61
11 F: 5'-GTGTGGGTGGGAGGTGGAGCGGTG-3';
R: 5'-AGGGAAGGCCTGTGATGGCGTCGG-3'
301 65
12 F: 5'-GCAGGCAAGTGGCAGTCCC-3';
R: 5'-GGCAAGTGGCCCGAGTGAC-3'
253 68
13 F: 5'-GGGGCTTGAGGGAATGAG-3';
R: 5'-CCTGACCCCAGGCTTCTC-3'
300 62
14 F: 5'-CAGGGCAGTACTGGGTGG-3';
R: 5'-TATATTGCAAAGGGGGTGATG-3'
331 62
F: forward primer; R: reverse primer.
Table 3 - Restriction enzyme tests for 3 known mutations in MPS I patients.
Phenotype Mutation Primers Restriction enzyme Fragment sizes (bp)
Hurler p.Q70X (exon 2) F: 5'-CGCTGCCAGCCATGCTGAGGCTCG-3';
R: 5'-ACACAGGGATGCTCACGGGTGACC-3'
–Sau96I N:310+99+57+5
M:310+156+5
Hurler p.W402X (exon 9) F: 5'-TGGCGGGGCCTGGGGACTCCTTCACCTA-3';
R: 5'-GCGGGTGTCGTCGCTCGCGTAGAT-3'
+BfaI N:26+248
M:26+110+138
Scheie p.R89Q (exon 2) F: 5'-CGCTGCCAGCCATGCTGAGGCTCG-3';
R: 5'-ACACAGGGATGCTCACGGGTGACC-3'
–MspI N:312+159
M:471
All PCR reactions were carried out with 200 ng genomic DNA.
(N normal; M mutant; +/– gain or loss of restriction enzyme site respectively).the Chinese MPS I families were c.1190-1G > A and
c.792+1G > T, respectively. 4 previously reported poly-
morphisms, viz., p.R105Q, p.L118, p.A314 and p.A361T,
were found. All sequence changes were confirmed by re-
striction enzyme testing on a second PCR product.
A mutant construct was generated, in order to deter-
mine whether the novel missense mutation p.R363H was
disease-causing.CHOcellsweretransfectedwitheitherthe
wild-type or a mutant construct, using lipofectamine. The
mutant construct reduced IDUA enzyme activity to
2.1 nmol/h/mg protein, whereas enzyme activity in CHO
cells transfected with the wild-type was 90.8 nmol/h/mg
protein. p.R363H expression showed retention of 2.3%
IDUA activity, thereby implying that this novel mutation
is, in fact, pathogenic.
MPSIiscausedbymutationsoftheIDUAgene,these
including missense and nonsense, splice-site, and insertion
or deletion mutations. The Han Chinese ethnic group is the
most populous in the world, whereby the significance of
specifically identifying the molecular genetical back-
ground of MPS I patients in this assemblage. 80% (16 out
of 20) of the alleles in the 10 Han Chinese MPS I families
studied, were identified. The four unidentified ones are
probablysituatedfurtherwithintheintronicorpromoterre-
gions, not included in this study. The method employed
could also be in arrear. The results of screening for known
mutationsshowedthatp.W402Xandp.Q70X,themostfre-
quentmutationsinEuropeanpatients,didnotappearinHan
Chinese MPS I patients. Moreover, p.R89Q, the most com-
mon mutant IDUA allele in Japanese MPS I patients, and
othermutations,suchasp.Y64X,p.Q310X,p.T366P(Bach
et al., 1993), p.P228Q, p.S534X, p.Y618X, c.193delT (Lee
et al., 2004) and p.E299X (Ketudat Cairns et al., 2005) in
Asian MPS I patients, were also not found in the Han Chi-
nese.
The two missense mutations, p.Q60X and p.D203N,
were previously described in a Chinese MPS IS patient
(Dou et al., 2007), and p.Q60X alone as a rare IDUA allele
in MPS I patients from the UK (Beesley et al., 2001), al-
though p.D203N has, as yet, not been identified in patients
elsewhere. Furthermore, eight rare IDUA alleles were
found in MPS I patients from Chinese Taipei. These in-
cluded two previously reported missense mutations,
p.Y343X (Voskoboeva et al., 1998) and p.A79V (Yoga-
lingam et al., 2004), as well as four missense mutations,
p.T364M (Lee-Chen and Wang, 1997), p.R619G (Lee-
Chenetal.,1999),andp.L346Randp.Q584X(Lee-Chenet
al., 2002), one splice-site mutation c.388-3C > G (Teng et
al.,2000),andonedeletionmutationc.46_57deluniquefor
China. IDUA gene mutations identified in Chinese MPS I
patients are listed in Table 4. A screening for the known
mutation in 35 Chinese MPS I patients revealed that
p.W402X, p.Q70X, p.P533R and p.R89Q were not present
among 70 alleles of the IDUA gene (Yu et al., 2001). Un-
fortunately, there is a lack of pertinent information regard-
ing the patients' ethnic group in the literature.
Thus, it is shown that Chinese MPS I patients are
characterized with a unique set of IDUA gene mutations,
not only different from those encountered among Europe-
ans and Americans, but also apparently diverse from those
present in other Asian populations. Furthermore, p.W402X
and p.Q70X were absent from Asian MPS I patients,
thereby emphasizing their uniqueness.
Genotype-phenotype correlations have been re-
ported, as, for example, the p.W402X and p.Q70X Hurler
mutations.Thesehavebeenshowntobeparticularlypreva-
lent (72%) in north European populations, with a high pro-
portion of severely affected patients. Nevertheless, several
mutations, such as p.P533R, seemed to correlate to differ-
entphenotypesinItalianMPS-Ipatients(Gattietal.,1997),
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Table 4 - Summary of IDUA mutations in Chinese MPS-I patients.
Mutation Codon change Location Associated phenotype Mutation type Reference
c.46_57del - Exon 1 Hurler Deletion mutation Lee-Chen et al. 2002
p.Q60X CAG-TAG Exon 2 Scheie Missense mutation Dou et al. 2007
p.A79V GCC-GTC Exon 2 Hurler/ Scheie Missense mutation Lee-Chen et al. 2002
c.388-3C > G - Intron 2 Hurler Splice mutation Teng et al. 2000
p.D203N GAT-AAT Exon 6 Scheie Missense mutation Dou et al. 2007
c.792+1G > T* - Intron 6 Hurler Splice mutation This study
p.Y343X TAC-TAG Exon 8 Hurler/ Scheie Nonsense mutation Lee-Chen et al. 1997
p.L346R CTG-CGG Exon 8 Hurler/ Scheie Missense mutation Teng et al. 2000
p.R363H* CGC-CAC Exon 8 Hurler/ Scheie Missense mutation This study
p.T364M ACG-ATG Exon 8 Hurler/ Scheie Missense mutation Lee-Chen et al. 1997
c.1190-1G > A* - Intron 8 Hurler Splice mutation This study
p.Q584X CAG-TAG Exon 13 Hurler Nonsense mutation Lee-Chen et al. 2002
p.R619G CGA-GGA Exon 14 Hurler/ Scheie Missense mutation Lee-Chen et al. 1999
*Unique mutations in Han Chinese MPS I families.while a patient homozygous for p.W402X, and presenting
the less severe Scheie phenotype, has also been described
(Pereira et al., 2008). On the other hand, missense muta-
tions distributed along the entire length of the gene may be
associated with severe phenotypes (Vazna et al., 2009).
Most of the patients were severely affected in the
casesunderstudy.Thehomozygoteforbothc.1190-1G>A
and c.792+1G > T, as well as the heterozygote for
c.1190-1G > A and c.792+1G > T, exhibited the Hurler
syndrome. Thus, these two mutations might be associated
with a severe phenotype, consistent with Terlato's idea that
most splice-site mutations result in a severe phenotype, un-
less in combination with a less severe missense mutation
(Terlato and Cox, 2003). c.1190-1G > A and c.792+1G > T
were further analyzed at the transcript level, whereupon
they proved to be acceptor and donor splice-site mutations,
respectively, thus presumably leading to a frameshift.
Moreover, these mutations were absent from 50 unrelated
controls, thereby implying their probable pathogenicity.
The only Hurler/Scheie syndrome patient was the
heterozygote for c.1190-1G > A/p.R363H. The novel
p.R363H missense mutation was due to a G to C trans-
version in codon 363, thereby resulting in the substitution
ofahistidinebyanarginineresidue.Itisgenerallyaccepted
thatlesssevereH/Ssyndromepatientsareassociatedwitha
milder allele that produces some residual enzyme activity.
Thus,asc.1190-1G>Ahomozygotespossessaseverephe-
notype, p.R363H can be most likely associated with a mild
to intermediate one. p.R363H expression showed retention
of 2.3% IDUA activity, thus in accordance with that pre-
dicted. The analogous mutation p.R363C (substitution of a
cysteine by an arginine residue) has been previously re-
ported (Yogalingam et al., 2004), although no IDUA activ-
ity was detected in CHO p.R363C cells. This is possibly
due to those conformational changes in IDUA taking place
onthebasicaminoacid,beingreplacedbyneutralcysteine,
thereby leading to a loss in enzyme activity.
Identification of IDUA mutations in the 10 Chinese
MPS I families permits accurate carrier detection and ge-
netic counseling of at-risk relatives, and should facilitate
molecular prenatal diagnosis in China. Moreover, thereby
genetic clues for the diagnosis and treatment of overseas
Chinese MPS I patients might be provided, due to their
unique IDUA gene mutations. The available treatments for
MPS I patients include hematopoietic stem cell transplants
and enzyme replacement therapy. Genotype studies assist
in the prediction of disease severity in MPS I patients, and
could, together with the age of the patient at diagnosis, aid
in taking a decision regarding treatment measures. Re-
cently, a further more efficacious treatment for MPS I
Hurler patients-hematopoietic stem-cell gene therapy,
based on lentiviral vectors and the success with mouse
models, completely corrects disease manifestations (Visi-
galli et al., 2010). Our data provide additional evidence for
the future development of clinically testing this same ther-
apy.
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